Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Source ↗
👁 0
💬 0
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Comments (0)